Advertisement
Perspective

Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

A New Deal for Global Health R&D? The Recommendations of the Consultative Expert Working Group on Research and Development (CEWG)

  • John-Arne Røttingen mail,

    John-Arne.Rottingen@kunnskapssenteret.no

    Affiliations: Department of Health Management and Health Economics, Institute for Health and Society, University of Oslo, Oslo, Norway, Harvard Kennedy School, Harvard University, Cambridge, Massachusetts, United States of America

    X
  • Claudia Chamas

    Affiliation: Centre for Technological Development in Health, Fiocruz, Rio de Janeiro, Brazil

    X
  • Published: May 15, 2012
  • DOI: 10.1371/journal.pmed.1001219
  • Featured in PLOS Collections

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?

Suerie Moon, Jorge Bermudez, Ellen 't Hoen
Essay | published 15 May 2012 | PLOS Medicine
doi:10.1371/journal.pmed.1001218